Hereditary epilepsy syndromes

Clinical Neurology and Neurosurgery

Volumn 99, Issue 3, 1997, Pages 159-171

  Callenbach, Petra M C ^a   Brouwer, Oebele F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Epilepsy; Genetics; Review

Indexed keywords

CLINICAL FEATURE; EPILEPSY; GENE LOCATION; GENETIC DISORDER; GENETICS; HUMAN; INHERITANCE; MYOCLONUS EPILEPSY; REVIEW;

CHROMOSOME MAPPING; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; EPILEPSY; GENETIC MARKERS; HUMANS; LINKAGE (GENETICS); MENTAL RETARDATION; PEDIGREE; SEIZURES; SYNDROME;

EID: 0030880109     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-8467(97)00019-X     Document Type: Review

References (135)

1. Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
2. Treiman LJ. Genetics of epilepsy: An overview. Epilepsia 1993;34(Suppl 3):S1-S11.
3. Rees M, Gardiner M. The molecular genetics of the epilepsies. In: Hopkins A, Shorvon S, Cascino G, editors. Epilepsy, 2nd edn. London: Chapman and Hall, 1995:93-103.
4. Wallace SJ. Seizures in children. In: Laidlaw J, Richens A, Chadwick D, editors. A Textbook of Epilepsy, 4th edn. New York: Churchill Livingstone, 1993:77-164.
5. Leppert M, Anderson VE, Quattlebaum T, Stauffer D, O'Connell P, Nakamura Y, Lalouel JM, White R. Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 1989;337:647-8.
6. Lewis TB, Leach RJ, Ward K, O'Connell P, Ryan SG. Genetic heterogeneity in benign familial neonatal convulsions: Identification of a new locus on chromosome 8q. Am. J. Hum. Genet. 1993;53:670-5.
7. Steinlein O, Schuster V, Fischer C, Häussler M. Benign familial neonatal convulsions: Confirmation of genetic heterogeneity and further evidence for a second locus on chromosome 8q. Hum. Genet. 1995;95:411-5.
8. Bouma PAD, Westendorp RGJ, Van Dijk JG, Peters ACB, Brouwer OF. The outcome of absence epilepsy: A meta-analysis. Neurology 1996;47:802-8.
9. Berkovic SF, Howell RA, Hopper JJ, Hay DA, Andermann E. A twin study of the epilepsies. Epilepsia 1990;31:813.
10. Beck-Mannagetta G, Janz D. Syndrome-related genetics in generalized epilepsy. Epilepsy Res. 1991;32(Suppl 4):105-11.
11. Serratosa JM, Weissbecker K, Delgado-Escueta AV. Childhood absence epilepsy: An autosomal recessive disorder?. Epilepsia 1990;31:651-2.
12. Serratosa J, Delgado-Escueta A, Liu A, Pascual-Castroviejo I, Wang G, Sparkes R. Exclusion of linkage between DNA markers in the juvenile myoclonic epilepsy locus of chromosome 6p and childhood absence epilepsy. Epilepsia 1993;34(Suppl 2):S149.
13. Sander T, Hildmann T, Wienker TF, Ramel C, Beck-Mannagetta G, Bianchi A, Sailer U, Berek K, Bauer G, Neitzel H, Schmitz B, Durner M, Johnson KJ, Janz D. Common subtypes of idiopathic generalized epilepsies: Lack of linkage to D20S19 close to candidate loci (EBN1, EEGV1) on chromosome 20. Am. J. Med. Genet. 1996;67:31-9.
14. Zara F, Bianchi A, Avanzini G. Di Donate S, Castellotti B, Patel PI, Pandolfo M. Mapping of genes predisposing to idiopathic generalized epilepsy. Hum. Mol. Genet. 1995;4:1201-7.
15. Ranta S, Tahvanainen E, Hirvasniemi A, Karila E, Sistonen P, Leisti J, Weissenbach J, Lehejoski AE, De la Chapelle A. A gene defect causing a novel progressive epilepsy with mental retardation, EPMR, maps to chromosome 8p. Am. J. Hum. Genet. 1994;55(Suppl 3):A16.
16. Hirvasniemi A, Herrala P, Leisti J. Northern epilepsy syndrome: Clinical course and the effect of medication on seizures. Epilepsia 1995;36:792-7.
17. Hirvasniemi A, Lang H, Lehejoski AE, Leisti J. Northern epilepsy syndrome: An inherited childhood onset epilepsy with associated mental deterioration. J. Med. Genet. 1994;31:177-82.
18. Tahvanainen E, Ranta S, Hirvasniemi A, Karila E, Leisti J, Sistonen P, Weissenbach J, Lehesjoki AE, De la Chapelle A. The gene for a recessively inherited human childhood progressive epilepsy with mental retardation maps to the distal short arm of chromosome 8. Proc. Natl. Acad. Sci. USA 1994;91:7267-70.
19. Berkovic SF, Andermann F, Andermann E, Gloor P. Concepts of absence epilepsies: Discrete syndromes or biological continuum?. Neurology 1987;37:993-1000.
20. Panayiotopoulos CP, Obeid T, Waheed G. Absences in juvenile myoclonic epilepsy: A clinical and video-electroencephalographic study. Ann. Neurol. 1989;25:391-7.
21. Reutens DC, Berkovic SF. Idiopathic generalized epilepsy of adolescence: Are the syndromes clinically distinct?. Neurology 1995;45:1469-76.
22. Sander T, Hildmann T, Janz D, Wienker TF, Neitzel H, Bianchi A, Bauer G, Sailer U, Berek K, Schmitz B, Beck-Mannagetta G. The phenotypic spectrum related to the human epilepsy susceptibilty gene EJM1. Ann. Neurol. 1995;38:210-7.
23. Greenberg DA, Delgado-Escueta AV, Widelitz H, Sparkes RS, Treiman L, Maldonado HM, Park MS, Terasaki PI. Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am. J. Med. Genet. 1988;31:185-92.
24. Delgado-Escueta AV, Greenberg DA, Treiman L, Liu A, Sparkes RS, Barbetti A, Park MS, Terasaki PI. Mapping the gene for juvenile myoclonic epilepsy. Epilepsia 1989;30(Suppl 4):S8-S18.
25. Delgado-Escueta AV, Greenberg D, Weissbecker K, Liu A, Treiman L, Sparkes RS, Park MS, Barbetti A, Terasaki PI. Gene mapping in the idiopathic generalized epilepsies: Juvenile myoclonic epilepsy, childhood absence epilepsy, epilepsy with grand mal seizures and early childhood myoclonic epilepsy. Epilepsia 1990;31(Suppl 3):S19-29.
26. Durner M, Sander T, Greenberg DA, Johnson K, Beck-Mannagetta G, Janz D. Localization of idiopathic generalized epilepsy on chromosome 6p in families of juvenile myoclonic epilepsy patients. Neurology 1991;41:1651-5.
27. Weissbecker KA, Durner M, Janz D, Scaramelli A. Sparkes RS, Spence MA. Confirmation of linkage between juvenile myoclonic epilepsy locus and the HLA region of chromosome 6. Am. J. Med. Genet. 1991;38:32-6.
28. Greenberg DA, Delgado-Escueta AV. The chromosome 6p epilepsy locus: Exploring mode of inheritance and heterogeneity through linkage analysis. Epilepsia 1993;34(Suppl 3):S12-8.
29. Delgado-Escueta AV, Serratosa JM, Liu AW, Medina MT, Sparkes RS. A juvenile myoclonic epilepsy locus proximal to HLA: The value of studying a large family. Epilepsia 1994;35(Suppl 7):8.
30. Whitehouse WP, Rees M, Curtis D, Sundqvist A, Parker K, Chung E, Baralle D, Gardiner RM. Linkage analysis of idiopathic generalized epilepsy (IGE) and marker loci on chromosome 6p in families of patients with juvenile myoclonic epilepsy: No evidence for an epilepsy locus in the HLA region. Am. J. Hum. Genet. 1993;53:652-62.
31. Elmslie FV, Williamson MP, Rees M, Kerr M, Kjeldsen MJ, Pang KA, Sundqvist A, Friis ML, Richens A, Chadwick D, Whitehouse WP, Gardiner RM. Linkage analysis of juvenile myoclonic epilepsy and microsatellite loci spanning 61 cM of human chromosome 6p in 19 nuclear pedigrees provides no evidence for a susceptibility locus in this region. Am. J. Hum. Genet. 1996;59:653-63.
32. Sander T, Janz D, Ramel C, Ross CA, Paschen W, Hildmann T, Wienker TF, Bianchi A, Bauer G, Sailer U, Berek K, Neitzel H, Volz A, Ziegler A, Schmit B, Beck-Mannagetta G. Refinement of map position of the human GluR6 kainate receptor gene (GRIK2) and lack of association and linkage with idiopathic generalized epilepsies. Neurology 1995;45:1713-20.
33. Green berg DA, Durner M, Resor D, Rosenbaum D, Shinnar S. The genetics of idiopathic generalized epilepsies of adolescent onset: Differences between juvenile myoclonic epilepsy and epilepsy with random grand mal and with awakening grand mal. Neurology 1995;45:942-6.
34. Singh R, Scheffer IE, Crossland K, Berkovic SF. Generalized epilepsy with febrile seizures plus: A new genetic syndrome. Epilepsia 1996;37(Suppl 5):115.
35. Lopes-Cendes I, Scheffer IE, Berkovic SF, Rousseau M, Andermann E, Rouleau GA. Mapping a locus for idiopathic generalized epilepsy in a large multiplex family. Epilepsia 1996;37(Suppl 5):127.
36. Vigevano F, Fusco L, DiCapua M, Ricci S, Sebastianelli R, Lucchini P. Benign infantile familial convulsions. Eur. J. Pediatr. 1992;151:608-12.
37. Echenne B, Humbertclaude V, Rivier F, Malafosse A, Cheminal R. Benign infantile epilepsy with autosomal dominant inheritance. Brain Dev. 1994;16:108-11.
38. Scheffer IE, Crossland KM, Shield LK, Perry N, Berkovic SF. Benign familial infantile convulsions-a dominant disorder not confined to the first year of life. Epilepsia 1996;37(Suppl 5):99.
39. Guipponi M, Rivier F, Vigevano F, Beck C, Crespel A, Echenne B, Lucchini P, Sebastianelli R, Baldy-Moulinier M, Malafosse A. Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum. Molec. Genet. 1997;6:473-7.
40. Whitehouse W, Diebold U, Rees M, Parker K, Doose H, Gardiner RM. Exclusion of linkage of genetic focal sharp waves to the HLA region on chromosome 6p in families with benign partial epilepsy with centrotemporal sharp waves. Neuropediatrics 1993;24:208-10.
41. Bouma PAD, Bovenkerk AC, Westendorp RGJ, Brouwer OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: A meta-analysis. Neurology 1997;48:430-7.
42. Rees M, Diebold U, Parker K, Doose H, Gardiner RM, Whitehouse WP. Benign childhood epilepsy with centrotemporal spikes and the focal sharp wave trait is not linked to the fragile X region. Neuropediatrics 1993;24:211-3.
43. Heijbel J, Blom S, Rasmuson M. Benign epilepsy of childhood with centrotemporal EEG foci-a genetic study. Epilepsia 1975;16:285-93.
44. Scheffer IE, Jones L, Pozzebon M, Howell RA, Saling MM, Berkovic SF. Autosomal dominant rolandic epilepsy and speech dyspraxia: A new syndrome with anticipation. Ann. Neurol. 1995;38:633-42.
45. Kuzniecky R, Rosenblatt B. Benign occipital epilepsy: A family study. Epilepsia 1987;28:346-50.
46. Scheffer IE, Bhatia KP, Lopes-Cendes I, Fish DR, Marsden CD, Andermann F, Andermann E, Desbiens R, Cendes F, Manson JI, Berkovic SF. Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet 1994;343:515-7.
47. Scheffer IE, Bhatia KP, Lopes-Cendes I, Fish DR, Marsden CD, Andermann E, Andermann F, Desbiens R, Keene D, Cendes F, Manson JI, Constantinou JEC, McIntosh A, Berkovic SF. Autosomal dominant nocturnal frontal lobe epilepsy: A distinctive clinical disorder. Brain 1995;118:61-73.
48. Nakken KO, Magnusson A. Autosomal dominant frontal epilepsy. Epilepsia 1996;37(Suppl 5):114.
49. Phillips HA, Scheffer IE, Berkovic SF, Hollway GE, Sutherland GR, Mulley JC. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q13.2. Nat. Genet. 1995;10:117-8.
50. Steinlein OK, Mulley JC, Propping P, Wallace RH, Phillips HA, Sutherland GR, Scheffer IE, Berkovic SF. A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 1995;11:201-3.
51. Tinuper P, Montagna P, Cerullo A, Plazzi G, Provini F, Mochi M, Lugaresi E. Autosomal dominant nocturnal epilepsy: A family with brain migration disorder and chromosome 18 duplication. Epilepsia 1996;37(Suppl 5):37.
52. Oilman R, Risch N, Hauser WA, Pedley TA, Lee JH, Barker-Cummings C, Lustenberger A, Nagle KJ, Lee KS, Scheuer ML, Neystat M, Susser M, Wilhelmsen KC. Localization of a gene for partial epilepsy to chromosome 10q. Nat. Genet. 1995;10:56-60.
53. Berkovic SF, McIntosh A, Howell RA, Mitchell A, Sheffield LJ, Hopper JL. Familial temporal lobe epilepsy: A common disorder identified in twins. Ann. Neurol. 1996;40:227-35.
54. Gambardella A, Aguglia U, Le Piane E, Messina D, Quattrone A. Autosomal dominant temporal lobe epilepsy. A large family from southern Italy. Epilepsia 1996;37(Suppl 5):115.
55. Matthews WB, Wright FK. Hereditary primary reading epilepsy. Neurology 1967;17:919-21.
56. Daly RF, Forster FM. Inheritance of reading epilepsy. Neurology 1975;25:1051-4.
57. Lasater GM. Reading epilepsy. Arch. Neurol. 1962;6:492-495.
58. Rowan AJ, Heathfield KWG, Scott DF. Is reading epilepsy inherited?. J. Neurol. Neurosurg. Psychiatry 1970;33:476-8.
59. Forster FM, Daly RF. Reading epilepsy in identical twins. Trans. Am. Neurol. Assoc. 1973;98:186-8.
60. Scheffer IE, Phillips H, Mulley J, Sutherland G, Harvey AS, Hopkins IJ, Berkovic SF. Autosomal dominant partial epilepsy with variable foci is not allelic with autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia 1995;36(Suppl 3):S28.
61. Berkovic SF, Cochius J, Andermann E, Andermann F. Progressive myoclonus epilepsies: Clinical and genetic aspects. Epilepsia 1993;34(Suppl 3):S19-30.
62. Gardiner M, Sandford A, Deadman M, Poulton J, Cookson W, Reeders S, Jokiaho I, Peltonen L, Eiberg H, Julier C. Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16. Genomics 1990;8:387-90.
63. Sharp J, Savukoski M, Wheeler RB, Harris J, Järvelä I. Peltonen L, Gardiner M, Williams R. Linkage analysis of late-infantile neuronal ceroid lipofuscinosis. Am. J. Med. Genet. 1995;57:348-9.
64. Zeman W, Donahue S, Dyken P, Green J. The neuronal ceroid-lipofuscinoses (Batten-Vogt syndrome). In: Vinken PJ, Bruyn GW, editors. Handbook of Clinical Neurology, Amsterdam: North-Holland, 1970;(10):588-679.
65. Dyken P, Wisniewski K. Classification of the neuronal ceroid lipofuscinoses: expansion of the atypical forms. Am. J. Med. Genet. 1995;57:150-4.
66. Shorvon S. The classic genetics of the epilepsies. In: Hopkins A, Shorvon S, Cascino G, editors. Epilepsy, 2nd edn, Chapman and Hall, London, 1995:87-92.
67. Hellsten E, Vesa J, Speer MC, Mäkelä TP, Järvelä I, Alitalo K, Ott J, Peltonen L. Refined assignment of the infantile neuronal ceroid lipofuscinosis (INCL, CLN1) locus at 1p32: Incorporation of linkage disequilibrium in multipoint analysis. Genomics 1993;16:720-5.
68. Buchhalter JR. Inherited epilepsies of childhood. J. Child Neurol. 1994;2:S12-9.
69. Savukoski M, Kestilä M, Williams R, Järvela ̈ I, Sharp J, Harris J, Santavuori P, Gardiner M, Peltonen L. Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. Am. J. Hum. Genet. 1994;55:695-701.
70. Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995;376:584-7.
71. Eiberg H, Gardiner RM, Mohr J. Batten disease (Spielmeyer-Sjogren disease) and haptoglobins (HP): Indication of linkage and assignment to chromosome 16. Clin. Genet. 1989;36:217-8.
72. Mitchison HM, Taschner PEM, O'Rawe AM, De Vos N, Phillips HA, Thompson AD. Kozman HM, Haines JL, Schlumpf K, D'Arigo K, Boustany RMN, Callen DF, Breuning MH, Gardiner RM, Mole SE, Lerners TJ. Genetic mapping of the Batten disease locus (CLN3) to the interval D16S288-D16S383 by analysis of haplotypes and allelic association. Genomics 1994;22:465-8.
73. Taschner PEM, De Vos N, Thompson AD, Gallen D F, Doggett N, Mole SE, Dooley TP, Barth PG, Breuning MH. Chromosome 16 microdeletion in a patient with juvenile neuronal ceroid lipofuscinosis (Batten disease). Am. J. Hum. Genet. 1995;56:663-8.
74. Williams R, Vesa J, Järvelä I, McKay T, Mitchison H, Hellsten E, Thompson A, Gallen D, Sutherland G, Luna-Battadano D, Stallings R, Peltonen L, Gardiner M. Genetic heterogeneity in neuronal ceroid lipofuscinosis (NCL): Evidence that the late-infantile subtype (Jansky-Bielschowsky disease; CLN2) is not an allelic form of the juvenile or infantile subtypes. Am. J. Hum. Genet. 1993;53:931-5.
75. Delgado-Escueta AV, Serratosa JM, Liu A, Weissbecker K, Medina MT, Gee M, Treiman LJ, Sparkes RS. Progress in mapping human epilepsy genes. Epilepsia 1994;35(Suppl 1):S29-40.
76. Seeman PJV, Finckh U, Höppner J, Lakner V, Liebisch I, Grau G, Rolfs A. Two new missense mutations in a non-Jewish Caucasian family with type 3 Gaucher disease. Neurology 1996;46:1102-7.
77. Barneveld RA, Keijzer W, Tegelaers FPW, Ginns EI, Geurts van Kessel A, Brady RO, Barranger JA, Tager JM, Galjaard H, Westerveld A, Reuser AJJ. Assignment of the gene coding for human β-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies. Hum. Genet. 1983;64:227-31.
78. Lehesjoki AE, Koskiniemi M, Sistonen P, Miao J, Hästbacka J, Norio R, De la Chapelle A. Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proc. Natl. Acad. Sci. USA 1991;88:3696-9.
79. Virtaneva K, Miao J. Träskelin AL, Stone N, Warrington JA, Weissenbach J, Myers RM, Cox DR, Sistonen P, De la Chapelle A, Lehesjoki AE. Progressive myoclonus epilepsy EPM1 locus maps to a 175-kb interval in distal 21q. Am. J. Hum. Genet. 1996;58:1247-53.
80. Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, Miao J, D'Amato E, Ramirez L, Faham M, Koskiniemi M, Warrington JA, Norio R, De la Chapelle A, Cox DR, Myers RM. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996;271:1731-4.
81. Lehesjoki AE, Virtaneva K, D'Amato E, Miao J, Pennacchio L, Myers RM, Avanzini G, Tassinari CA, De la Chapelle A. Mutation analysis of the cystatin B gene in progressive myoclonus epilepsy, EPM1 patients. Epilepsia 1996;37(Suppl 5):127.
82. Yamakawa K, Mitchell S, Hubert R, Chen XN, Colbern S, Huo YK, Gadomski C, Kim UJ, Korenberg JR. Isolation and characterization of a candidate gene for progressive myoclonus epilepsy on 21q22.3. Hum. Mol. Genet. 1995;4:709-16.
83. Lalioti MD, Cos A, Green MR, Rossier C, Morris MA, Antonarakis SE. The gene for human U2 snRNP auxiliary factor small 35-kDa subunit (U2AF1) maps to the progressive myoclonus epilepsy (EPM1) critical region on chromosome 21q22.3. Genomics 1996;33:298-300.
84. Rosing HS, Hopkins LC, Wallace DC, Epstein CM, Weidenheim K. Maternally inherited mitochondrial myopathy and myoclonic epilepsy. Ann. Neurol. 1985;17:228-37.
85. Lys mutation. Cell 1990;61:931-7.
86. Lys of patients with myoclonus epilepsy associated with ragged-red fibers. Biochem. Int. 1990;21:789-96.
87. Rapin I, Goldfischer S, Katzman R, Engel J, O'Brien JS. The cherry-red-spot myoclonus syndrome. Ann. Neurol. 1978;3:234-42.
88. Thomas GH, Beaudet AL. Disorders of glycoprotein degradation and structure: α-Mannosidosis, β-mannosidosis, fucosidosis, sialidosis, aspartylglucosaminuria and carbohydrate-deficient glycoprotein syndrome. In: Scriver CR, Beaudet AL, Sly WL, Valle D, editors. The Metabolic and Molecular Basis of Inherited Disease, vol.2. New York: McGraw-Hill, 1995;2529-2561.
89. Mueller OT, Henry WM, Haley LL, Byers MG, Eddy RL, Shows TB. Sialidosis and galactosialidosis: Chromosomal assignment of two genes associated with neuraminidase-deficiency disorders. Proc. Natl. Acad. Sci. USA 1986;83:1817-21.
90. Naito H, Oyanagi S. Familial myoclonus epilepsy and choreoathetosis: Hereditary dentatorubral-pallidoluysian atrophy. Neurology 1982;32:798-807.
91. Uyama E, Kondo I, Uchino M, Fukushima T, Murayama N, Kuwano A, Inokuchi N, Ohtani Y, Ando M. Dentatorubral-pallidoluysian atrophy (DRPLA): Clinical, genetic and neuro-radiologic studies in a family. J. Neurol. Sci. 1995;130:146-53.
92. Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T, Saito M, Tomoda A, Miike T, Naito H, Ikuta F, Tsuji S. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat. Genet. 1994;6:9-13.
93. Sano A. Yamauchi N, Kakimoto Y, Komure O, Kawai J, Hazama F, Kuzume K, Sano N, Kondo I. Anticipation in hereditary dentatorubral-pallidoluysian atrophy. Hum. Genet. 1994;93:699-702.
94. Komure O, Sano A, Nishino N, Yamauchi N, Ueno S, Kondoh K, Sano N, Takahashi M, Murayama N, Kondo I, Nagafuchi S, Yamada M, Kanazawa I. DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: Correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation. Neurology 1995;45:143-9.
95. Takano T, Yamanouchi Y, Nagafuchi S, Yamada M. Assignment of the dentatorubral and pallidoluysian atrophy (DRPLA) gene to 12pl3.31 by fluorescence in situ hybridisation. Genomics 1996;32:171-2.
96. Van Heycop ten Ham, MW. Lafora disease: A form of progressive myoclonus epilepsy. In: Vinken PJ, Bruyn, GW, editors. Handbook of Clinical Neurology, vol. 15. Amsterdam: North-Holland, 1974:382-422.
97. Serratosa JM, Delgado-Escueta AV, Posada I, Shih S, Drury I, Berciano J, Zabala JA, Antúnez MC, Sparkes RS. The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum. Mol. Genet. 1995;4:1657-63.
98. Maddox LO, Keating J, Descartes M, Collins J, Rosenfeld S, Gilliam F, Kuzniecky R. Identification of a recombination event narrowing the Lafora gene region. Epilepsia 1996;37(Suppl 5): 115.
99. Minassian BA, Sainz J, Bohlega S, Sakamoto LM, Delgado-Escueta AV. Genetic heterogeneity in Lafora's disease. Epilepsia 1996;37(Suppl 5):126.
100. Gomez MR. Tuberous Sclerosis. New York: Raven Press, 1988.
101. Fryer AE, Chalmers A, Connor JM, Fraser I, Povey S, Yates AD, Yates JRW, Osborne JP. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1987;1:659-61.
102. Kandt RS, Haines JL, Smith M, Nothrup H, Gardner RJM, Short MP, Dumars K, Roach ES, Steingold S, Wall S, Blanton SH, Flodman P, Kwiatkowski DJ, Jewell A, Weber JL, Roses AD, Pericak-Vance MA. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat. Genet. 1992;2:37-41.
103. European chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-1315.
104. Anderson VE, Hauser WA. Genetics. In: Laidlaw J, Richens J, Chadwick A, editors. A Textbook of Epilepsy. 4th edn. New York: Churchill Livingstone, 1993:47-75.
105. Duffner PK, Cohen ME, Seidel FG, Shucard DW. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989;39:373-8.
106. North K. Neurofibromatosis type 1: Review of the first 200 patients in an Australian clinic. J. Child. Neurol. 1993;8:395-402.
107. Colman SD, Wallace MR. Neurofibromatosis type 1. Eur. J. Cancer 1994;30A:1974-81.
108. Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Faryniarz AG, Chao MV, Huson S, Korf BR, Parry DM, Pericak-Vance MA, Collins FS, Hobbs WJ, Falcone BG, lannazzi JA, Roy JC, St George-Hyslop PH, Tanzi RE, Bothwell MA, Upadhyaya M, Harper P, Goldstein AE, Hoover DL, Bader JL, Spence MA, Mulvihill JJ, Aylsworth AS, Vance JM, Rossenwasser GOD, Gaskell PC, Roses AD, Martuza RL, Breakefield XO, Gusella JF. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 1987;49:589-594.
109. Barker D, Wright E, Nguyen K, Cannon C, Fain P, Goldgar D, Bishop DT, Carey J, Baty B, Kivlin J, Willard H, Waye JS, Greig G, Leinwand L, Nakamura Y, O'Conell P, Leppert M, Lalouel JM, White R, Sholnick M. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 1987;236:1098-102.
110. Stafstrom CE. Epilepsy in Down syndrome: Clinical aspects and possible mechanisms. Am. J. Ment. Retard. 1993;98:S12-26.
111. MacGillivray RC. Epilepsy in Down's anomaly. J. Ment. Defic. Res. 1967;11:43-8.
112. Lejeune J, Gautier M, Turpin R. Etude des chromosomes somatiques de neuf enfants mongoliens. C.R. Acad. Sci. 1959;248:1721.
113. Korf BR. Chromosomal abnormalities. In: Taeusch HW, Ballard RA, Avery ME, editors. Schaffer and Avery's Diseases of the Newborn, 6th edn. Philadelphia: Saunders, 1991:104-110.
114. Hecht F. Seizure disorders in the fragile X chromosome syndrome. Am. J. Med. Genet. 1991;38:509.
115. Laxova R. Fragile X syndrome. Adv. Pediatr. 1994;41:305-342.
116. Musumeci SA, Ferri R, Elia M, Colognola RM, Bergonzi P, Tassinari CA. Epilepsy and fragile X syndrome: A follow-up study. Am. J. Med. Genet. 1991;38:511-3.
117. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-14.
118. Krawczun MS, Jenkins EC, Brown WT. Analysis of the fragile-X chromosome: Localization and detection of the fragile site in high resolution preparations. Hum. Genet. 1985;69:209-11.
119. Pembrey M, Fennell SJ, Van den Berghe J, Fitchett M, Summers D, Butler L. Clarke C, Griffiths M, Thompson E, Super M, Baraitser M. The association of Angelman's syndrome with deletions within 15q11-13. J. Med. Genet. 1989;26:73-7.
120. Laan LAEM, Renier WO, Arts WFM, Buntinx IM, Van de Burgt IJAM, Stroink H, Beuten J, Zwinderman KH, Van Dijk JG, Brouwer OF. Evolution of epilepsy and EEG findings in Angelman syndrome. Epilepsia 1997;38:195-9.
121. Laan LAEM, Den Boer ATh, Hennekam RCM, Renier WO, Brouwer OF. Angelman syndrome in adulthood. Am. J. Med. Genet. 1996;66:356-60.
122. Knoll JHM, Nicholls RD, Magenis RE, Graham JM, Lalande M, Latt SA. Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am. J. Med. Genet. 1989;32:285-90.
123. 3 subunit to the Angelman/Prader-Willi region of human chromosome 15. Am. J. Hum. Genet. 1991;49:1330-7.
124. Knoll JHM, Sinnett D, Wagstaff J, Glatt K, Schantz Wilcox A, Whiting PM, Wingrove P, Sikela JM, Lalande M. FISH ordering of reference markers and of the gene for the α5 subunit of the γ-aminobutyric acid receptor (GABRA5) within the Angelman and Prader-Willi syndrome chromosomal regions. Hum. Mol. Genet. 1993;2:183-9.
125. Greger V, Knoll JHM, Woolf E, Glatt K, Tyndale RF, DeLorey TM, Olsen RW, Tobin AJ, Sikela JM, Nakatsu Y, Brilliant MH, Whiting PJ, Lalande M. The γ-aminobutyric acid receptor γ3 subunit gene (GABRG3) is tightly linked to the α5 subunit gene (GABRA5) on human chromosome 15q11-q13 and is transcribed in the same orientation. Genomics 1995;26:258-64.
126. Guerrini R, Suisse G, Bonanni P, Dravet CH, Bureau M, Genton P, Thomas P, Livet MO, Sartucci F. Angelman syndrome: A genetic model of cortical myoclonus. Epilepsia 1995;36(Suppl 3):S27.
127. Knoll JHM, Glatt KA, Nicholls RD, Malcolm S, Lalande M. Chromosome 15 uniparental disomy is not frequent in Angelman syndrome. Am. J. Hum. Genet. 1991;48:16-21.
128. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 1997;15:70-3.
129. Matsuura T, Sutcliffe JS, Fang P. Galjaard RJ, Jiang Y, Benton CS, Rommens JM, Beaudet AL. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet. 1997;15:74-7.
130. Shin C, McNamara JO. Mechanism of epilepsy. Ann. Rev. Med. 1994;45:379-89.
131. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-3.
132. Ferrie CD, Jackson GD, Giannakodimos S, Panayiotopoulos CP. Posterior agyria-pachygyria with polymicrogyria: Evidence for an inherited neuronal migration disorder. Neurology 1995;45:150-3.
133. Kuwano A, Takakubo F, Morimoto Y, Uyama E, Uchino M, Ando M, Yasuda T, Terao A, Hayama T, Kobayashi R, Kondo I. Benign adult familial myoclonus epilepsy (BAFME): An autosomal dominant form not linked to the dentatorubral pallidoluysian atrophy (DRPLA) gene. J. Med. Genet. 1996;33:80-1.
134. Uyama E, Tokunaga M, Murakami T, Kuwano A, Kondo I, Uchino M. Familial adult myoclonus epilepsy: A new phenotype of autosomal dominant myoclonus epilepsy. Ann. Neurol. 1996;40:505.
135. Munke M, Kraus JP, Ohura T, Francke U. The gene for cystathionine β-synthase (CBS) maps to the subtelomeric region on chromosome 21q and to proximal mouse chromosome 17. Am. J. Hum. Genet. 1988;42:550-9.